HIV Treatment-Readiness Measure (HTRM) Validation
Completed
Conditions studied: HIV Infections
In brief
The goal of this study is to assess the reliability of the HIV Treatment Readiness Measure (HTRM) to assist clinicians in: (1) determining whether or not youth living with HIV are ready to initiate HAART and (2) identifying youth who may be in need of additional support services to facilitate their adherence to HAART. The current study will examine the psychometric properties of the HTRM and establish its test-retest reliability over a two week period. If the HTRM is found to be reliable, a subsequent study will examine its predictive validity.
Key facts
- Study ID
- NCT00686049
- Run by
- University of North Carolina, Chapel Hill
- People needed
- 200
- Starts
- 2008-05-01
- Expected to finish
- 2009-01-01
- Last updated by the study team
- 2017-02-28
Who can join
Age: 13 and older, up to 24. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- HIV-positive youth, 13 years 0 days to 24 years 364 days of age
- Either HAART naïve (defined as never having taken HAART) or HAART experienced (defined as having had at least one experience taking HAART and not having taken HAART for 30 days prior to study entry)
- Not currently on HAART, but planning to initiate HAART within the next 2 months based on provider recommendation
- Enrolled in care at an AMTU or a collaborating site
- Able to speak and understand English
- Willing to provide informed consent, or assent with parental permission (if required by the site IRB) for participation in this study.
You may not qualify if…
- Evidence of cognitive impairment or other mental condition that limits his/her ability to complete the assessment (per PI or designee discretion)
- Determined by the PI (or designee) to be under the influence of psychoactive agents or intoxicated at the time of assessment to a degree that would interfere with successful completion of the questionnaire
- Visibly distraught or unstable
- Any clinical condition that would likely interfere with the participant's ability to complete the study
- Participants who are unable to speak English will be excluded from the initial testing of the HTRM's reliability and validity in keeping with traditional tool development strategies. If the initial study indicates that the English version of the HTRM is reliable and valid, appropriate methods will be employed to translate the instrument into Spanish and the reliability and validity will be re-examined for the Spanish version.
Where it is running
- Childrens Hospital of Los Angeles — Los Angeles, California, United States
- University of California San Francisco — San Francisco, California, United States
- Childrens National Medical Center — Washington D.C., District of Columbia, United States
- Childrens Diagnostic & Treatment Center, Inc — Fort Lauderdale, Florida, United States
- University of Miami School of Medicine — Miami, Florida, United States
- USF College of Medicine — Tampa, Florida, United States
- Ruth M Rothstein CORE Center/ John H Stroger Jr Hospital — Chicago, Illinois, United States
- Childrens Memorial Hospital — Chicago, Illinois, United States
- Tulane University Health Sciences Center — New Orleans, Louisiana, United States
- University of Maryland Express Mailing Address: — Baltimore, Maryland, United States
- Mount Sinai Medical Center — New York, New York, United States
- Montefiore Medical Center — The Bronx, New York, United States
- The Childrens Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
- St Jude Childrens Research Hospital — Memphis, Tennessee, United States
- University of Puerto Rico, Medical Sciences Campus — San Juan, Puerto Rico
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.